Contractor intelligence · computed from public award records

NOVARTIS ARGENTINA

Awards won: 10
Known value: USD 11.1M
First award: 02 Feb 2018
Most recent: 23 Sept 2022

Wins by funder

Funder	Awards	Known value	Most recent
World Bank	8	USD 10.5M	23 Sept 2022
Inter-American Development Bank	2	USD 634K	20 Jul 2021

Where the work is

AR · 10

Sources

The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.

Adquisición de Inmunosupresores: MICOFENOLATO SODICO, EVEROLIMUS y CICLOSPORINA · 23 Sept 2022 · USD 5.7M · World Bank
Lote 1: VALGANCICLOVIR · 21 Jul 2022 · USD 394K · World Bank
Adquisición de Nilotinib 150 mg y 200 mg · 12 Jul 2022 · USD 691K · World Bank
Immediate Public Health Response Project en the context of the COVID-19 Pandemic to contain, control and mitigate its effect in health service provision in Argentina · 20 Jul 2021 · USD 353K · Inter-American Development Bank
MULTIPHASE PRIMARY HEALTH CARE PROGRAM FOR MANAGING CHRONIC NONCOMMUNICABLE DISEASES · 29 Jun 2020 · USD 280K · Inter-American Development Bank
Inmunosupresores INCUCAI 2018-2019 (Lote 1, 4, 5, 6, 7, 8, 9, 10, 15, 17, 18, 19, 23, 24, 26) · 14 Mar 2019 · USD 2.0M · World Bank
Inmunosupresores INCUCAI 2018-2019 (Lote 2, 4, 5, 6, 15, 17, 18, 23, 24) · 14 Mar 2019 · USD 359K · World Bank
Medicamentos Oncológicos (Lote 8, 9, 10) · 04 Feb 2019 · USD 4K · World Bank
Sandimmun Neoral / Ciclosprospina 100 mg · 02 Aug 2018 · USD 181K · World Bank
Medicación Inmunosupresora (Lotes 1, 2, 3, 4, 14, 15, 16, 26) · 02 Feb 2018 · USD 1.1M · World Bank

Method

Computed from 10 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.